DRUG SCHEDULE 13G/A: SEC filing
An institutional holder
Filed with the SEC on · accession 0000919574-26-004968
DRUG filed a SCHEDULE 13G/A (schedule 13g/a) with the SEC on Aug 12, 2026. An institutional holder filed an amended Schedule 13G for Bright Minds Biosciences Inc., indicating a change in its passive ownership position. The stock moved -1.1% by the first close after the filing.
Summary of the filing
An institutional holder filed an amended Schedule 13G for Bright Minds Biosciences Inc., indicating a change in its passive ownership position. The filing does not disclose a specific ownership percentage or share count in the available text.
Key details
How DRUG stock reacted
Close before
$80.25
Aug 11, 2026
First close after
-1.10%
$79.37
5 trading days
+4.72%
$84.04
Since filing
-71.34%
$23.00
✦ Ask GOAX AI about this filing — what it means for DRUG, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for DRUG?
Click hereFrequently asked questions
What did DRUG file with the SEC on Aug 12, 2026?
DRUG filed a SCHEDULE 13G/A (SEC filing). An institutional holder filed an amended Schedule 13G for Bright Minds Biosciences Inc., indicating a change in its passive ownership position. The filing does not disclose a specific ownership percentage or share count in the available text.
How do I read a SCHEDULE 13G/A?
A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13G/A (schedule 13g/a): A report the company filed with the SEC (the US market regulator).
How did DRUG stock react to this filing?
DRUG closed at $80.25 before the filing and $79.37 on Aug 12, 2026 (-1.10%). Five trading days later: $84.04 (+4.72%).
Other DRUG SEC filings
Get alerts when DRUG files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days